Zobrazeno 1 - 10
of 10
pro vyhledávání: ''
Autor:
Ana C. Calpena, Josefa Badia, Maria Luisa García, Camila Folle, Natalia Díaz-Garrido, Ana Marqués, Elena Sánchez-López, Marta Espina, Laura Baldomà
Publikováno v:
Journal of Nanobiotechnology, Vol 19, Iss 1, Pp 1-21 (2021)
Journal of Nanobiotechnology
Dipòsit Digital de la UB
Universidad de Barcelona
Journal of Nanobiotechnology
Dipòsit Digital de la UB
Universidad de Barcelona
Background Acne is a common skin disorder that involves an infection inside the hair follicle, which is usually treated with antibiotics, resulting in unbalanced skin microbiota and microbial resistance. For this reason, we developed polymeric nanopa
Autor:
Jin Xie, Shuyue Zhan, Wei Yang, Yong Teng, Shiyi Zhou, Weizhong Zhang, Zhengwei Cao, Anil Kumar, Wen Jiang, Rui Liu, Xueyuan Yang
Publikováno v:
Journal of Nanobiotechnology, Vol 19, Iss 1, Pp 1-11 (2021)
Journal of Nanobiotechnology
Journal of Nanobiotechnology
Background Photodynamic therapy (PDT) may elicit antitumor immune response in addition to killing cancer cells. However, PDT as a monotherapy often fails to induce a strong immunity. Immune checkpoint inhibitors, which selectively block regulatory ax
Publikováno v:
Journal of Nanobiotechnology, Vol 19, Iss 1, Pp 1-18 (2021)
Journal of Nanobiotechnology
Journal of Nanobiotechnology
Background Diabetes complications are the leading cause of mortality in diabetic patients. The common complications are decline in antioxidant capacity and the onset of micro-inflammation syndrome. At present, glucose-responsive nanoparticles are wid
Autor:
Yi-chuan Pang, Xian-kun Cao, Tong-chao Zhao, Lai-ping Zhong, Ying-ying Huang, Ming Qi, Meng Yang, Si-yuan Liang, Zhihang Zhou, Wu-tong Ju, Dong-wang Zhu, Xuzhuo Chen
Publikováno v:
Journal of Nanobiotechnology, Vol 19, Iss 1, Pp 1-14 (2021)
Journal of Nanobiotechnology
Journal of Nanobiotechnology
Background Smart nanoscale drug delivery systems that target acidic tumor microenvironments (TME) could offer controlled release of drugs and modulate the hypoxic TME to enhance cancer therapy. The majority of previously reported MnO2 nanostructures
Autor:
Xing Chen, Renjun Pei, Qishi Du, Li Liu, Dongping Huang, Dong Chen, Qunjiao Jiang, Xiaobo Yang, Gang Huang, Qiuying Li, Yi Cao
Publikováno v:
Journal of Nanobiotechnology, Vol 19, Iss 1, Pp 1-15 (2021)
Journal of Nanobiotechnology
Journal of Nanobiotechnology
Background Owing to high genetic diversities of tumor cells and low response rate of standard chemotherapy, patients with triple negative breast cancer (TNBC) have short progression-free survivals and poor outcomes, which need to explore an effective
Publikováno v:
Journal of Nanobiotechnology, Vol 19, Iss 1, Pp 1-11 (2021)
Journal of Nanobiotechnology
Journal of Nanobiotechnology
Background There is a strong need for non-invasive and patient-friendly delivery systems of protein drugs for long-term therapy. However, oral delivery of protein drugs is a big challenge due to many barriers including instability in the gastrointest
Autor:
Chunmei Hu, Dongfang Liu, Yinan Ding, Chen He, Kangli Xue, Qiusha Tang, Xihui Wang, Yanli An, Zhiyuan Zhang, Rui Yang
Publikováno v:
Journal of Nanobiotechnology, Vol 19, Iss 1, Pp 1-17 (2021)
Journal of Nanobiotechnology
Journal of Nanobiotechnology
Background Glioblastoma (GBM) is the most invasive primary intracranial tumor, and its effective treatment is one of the most daunting challenges in oncology. The blood–brain barrier (BBB) is the main obstacle that prevents the delivery of potentia
Autor:
Seokmann Hong, Hyo Kyung Han, So Youn Ro, Hyun Woo Ma, Jae Hee Cheon, I Seul Park, Jung Min Kim, Da Hye Kim, Hyo Jeong Park, Soo Jeong Lim, Seung Won Kim, Mi Jeong Son
Publikováno v:
Journal of Nanobiotechnology, Vol 18, Iss 1, Pp 1-13 (2020)
Journal of Nanobiotechnology
Journal of Nanobiotechnology
Infliximab (IFX), a TNF-α blocking chimeric monoclonal antibody, induces clinical response and mucosal healing in patients with inflammatory bowel disease (IBD). However, systemic administration of this agent causes unwanted side effects. Oral deliv
Autor:
Kaikai Wang, Linfeng Xu, Hongqian Guo, Wei Chen, Xiaozhi Zhao, Wenming Cao, Guanchen Zhu, Haixiang Qin
Publikováno v:
Journal of Nanobiotechnology, Vol 18, Iss 1, Pp 1-13 (2020)
Journal of Nanobiotechnology
Journal of Nanobiotechnology
Background Chemotherapy is a standard cancer treatment which uses anti-cancer drugs to destroy or slow the growth of cancer cells. However, chemotherapy has limited therapeutic effects in bladder cancer. One of the reasons of this resistance to chemo
Publikováno v:
Journal of Nanobiotechnology, Vol 17, Iss 1, Pp 1-27 (2019)
Journal of Nanobiotechnology
Journal of Nanobiotechnology
Background Nanoceria has recently received much attention, because of its widespread biomedical applications, including antibacterial, antioxidant and anticancer activity, drug/gene delivery systems, anti-diabetic property, and tissue engineering. Ma